Bulletin of the National Research Centre

Table 5 Predicted pharmacokinetic properties of test compounds

From: Molecular binding studies of anthocyanins with multiple antiviral activities against SARS-CoV-2

Compounds	BBB permeant	Pgp substrate	CYP1A2 inhibitor	CYP2C19 inhibitor	CYP2C9 inhibitor	CYP2D6 inhibitor	CYP3A4 inhibitor	Log Kp (cm/s)
C1	No	No	No	No	No	No	No	− 11.8
C2	No	Yes	No	No	No	No	No	− 13.12
C3	No	Yes	No	No	No	No	No	− 12.98
C4	No	Yes	No	No	No	No	No	− 13.73
C5	No	Yes	No	No	No	No	No	− 13.39
C6	No	No	No	No	No	No	No	− 11.84
C7	No	No	No	No	No	No	No	− 9
C8	No	No	No	No	No	No	No	− 13.12

Back to article page